Your browser doesn't support javascript.
loading
Sex Differences in Fractional Flow Reserve- or Intravascular Ultrasound-Guided Percutaneous Coronary Intervention.
Zhang, Jinlong; Jiang, Jun; Hu, Xinyang; Sun, Yong; Li, Changling; Zhu, Lingjun; Gao, Feng; Dong, Liang; Liu, Yabin; Shen, Jian; Ni, Cheng; Wang, Kan; Chen, Zexin; Chen, Haibo; Li, Shiqiang; Yang, Seokhun; Kang, Jeehoon; Hwang, Doyeon; Hahn, Joo-Yong; Nam, Chang-Wook; Doh, Joon-Hyung; Lee, Bong-Ki; Kim, Weon; Huang, Jinyu; Jiang, Fan; Zhou, Hao; Chen, Peng; Tang, Lijiang; Jiang, Wenbing; Chen, Xiaomin; He, Wenming; Ahn, Sung Gyun; Yoon, Myeong-Ho; Kim, Ung; Lee, Joo Myung; Ki, You-Jeong; Shin, Eun-Seok; Kim, Chee Hae; Tahk, Seung-Jea; Koo, Bon-Kwon; Wang, Jian'an.
Affiliation
  • Zhang J; Department of Cardiology, The Second Affiliated Hospital of Zhejiang University School of Medicine, State Key Laboratory of Transvascular Implantation Devices, Research Center for Life Science and Human Health, Binjiang Institute of Zhejiang University, Hangzhou, China.
  • Jiang J; Department of Cardiology, The Second Affiliated Hospital of Zhejiang University School of Medicine, State Key Laboratory of Transvascular Implantation Devices, Hangzhou, China.
  • Hu X; Department of Cardiology, The Second Affiliated Hospital of Zhejiang University School of Medicine, State Key Laboratory of Transvascular Implantation Devices, Research Center for Life Science and Human Health, Binjiang Institute of Zhejiang University, Hangzhou, China.
  • Sun Y; Department of Cardiology, The Second Affiliated Hospital of Zhejiang University School of Medicine, State Key Laboratory of Transvascular Implantation Devices, Hangzhou, China.
  • Li C; Department of Cardiology, The Second Affiliated Hospital of Zhejiang University School of Medicine, State Key Laboratory of Transvascular Implantation Devices, Hangzhou, China.
  • Zhu L; Department of Cardiology, The Second Affiliated Hospital of Zhejiang University School of Medicine, State Key Laboratory of Transvascular Implantation Devices, Hangzhou, China.
  • Gao F; Department of Cardiology, The Second Affiliated Hospital of Zhejiang University School of Medicine, State Key Laboratory of Transvascular Implantation Devices, Hangzhou, China.
  • Dong L; Department of Cardiology, The Second Affiliated Hospital of Zhejiang University School of Medicine, State Key Laboratory of Transvascular Implantation Devices, Hangzhou, China.
  • Liu Y; Department of Cardiology, The Second Affiliated Hospital of Zhejiang University School of Medicine, State Key Laboratory of Transvascular Implantation Devices, Hangzhou, China.
  • Shen J; Department of Cardiology, The Second Affiliated Hospital of Zhejiang University School of Medicine, State Key Laboratory of Transvascular Implantation Devices, Hangzhou, China.
  • Ni C; Department of Cardiology, The Second Affiliated Hospital of Zhejiang University School of Medicine, State Key Laboratory of Transvascular Implantation Devices, Hangzhou, China.
  • Wang K; Department of Cardiology, The Second Affiliated Hospital of Zhejiang University School of Medicine, State Key Laboratory of Transvascular Implantation Devices, Hangzhou, China.
  • Chen Z; Department of Cardiology, The Second Affiliated Hospital of Zhejiang University School of Medicine, State Key Laboratory of Transvascular Implantation Devices, Hangzhou, China.
  • Chen H; Department of Cardiology, The Second Affiliated Hospital of Zhejiang University School of Medicine, State Key Laboratory of Transvascular Implantation Devices, Hangzhou, China.
  • Li S; Department of Cardiology, The Second Affiliated Hospital of Zhejiang University School of Medicine, State Key Laboratory of Transvascular Implantation Devices, Hangzhou, China.
  • Yang S; Seoul National University Hospital, Seoul, Republic of Korea.
  • Kang J; Seoul National University Hospital, Seoul, Republic of Korea.
  • Hwang D; Seoul National University Hospital, Seoul, Republic of Korea.
  • Hahn JY; Samsung Medical Center, Seoul, Republic of Korea.
  • Nam CW; Keimyung University Dongsan Medical Center, Daegu, Republic of Korea.
  • Doh JH; Inje University Ilsan Paik Hospital, Goyang, Republic of Korea.
  • Lee BK; Kangwon National University Hospital, Chuncheon, Gangwon-Do, Republic of Korea.
  • Kim W; Kyung Hee University Hospital, Seoul, Republic of Korea.
  • Huang J; Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  • Jiang F; Hangzhou Normal University Affiliated Hospital, Hangzhou, China.
  • Zhou H; The 1st Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
  • Chen P; The 2nd Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
  • Tang L; Zhejiang Hospital, Hangzhou, China.
  • Jiang W; The Third Clinical Institute Affiliated To Wenzhou Medical University, Wenzhou, China.
  • Chen X; Ningbo First Hospital, Ningbo, China.
  • He W; The Affiliated Hospital of Medical School of Ningbo University, Ningbo, China.
  • Ahn SG; Wonju Severance Christian Hospital, Wonju, Gangwon-Do, Republic of Korea.
  • Yoon MH; Ajou University Hospital, Suwon, Republic of Korea.
  • Kim U; Yeungnam University Medical Center, Daegu, Republic of Korea.
  • Lee JM; Samsung Medical Center, Seoul, Republic of Korea.
  • Ki YJ; Uijeongbu Eulji Medical Center, Uijeongbu, Gyeonggi-Do, Republic of Korea.
  • Shin ES; Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Republic of Korea.
  • Kim CH; Veterans Health Service Medical Center, Seoul, Republic of Korea.
  • Tahk SJ; Ajou University Hospital, Suwon, Republic of Korea.
  • Koo BK; Seoul National University Hospital, Seoul, Republic of Korea. Electronic address: bkkoo@snu.ac.kr.
  • Wang J; Department of Cardiology, The Second Affiliated Hospital of Zhejiang University School of Medicine, State Key Laboratory of Transvascular Implantation Devices, Hangzhou, China. Electronic address: wja@zju.edu.cn.
JACC Cardiovasc Interv ; 16(19): 2426-2435, 2023 Oct 09.
Article in En | MEDLINE | ID: mdl-37638768
ABSTRACT

BACKGROUND:

A recent randomized trial reported fractional flow reserve (FFR)-guided percutaneous coronary intervention (PCI) strategy was noninferior to the intracoronary ultrasound (IVUS)-guided PCI strategy with respect to clinical outcomes with fewer revascularizations.

OBJECTIVES:

This study sought to investigate the sex differences in treatment and clinical outcomes according to physiology- or imaging-guided PCI strategies.

METHODS:

In this secondary analysis of the FLAVOUR (Fractional Flow Reserve or Intravascular Ultrasonography to Guide PCI) trial, the impact of sex on procedural characteristics, PCI rate, and outcomes according to different strategies and treatment types (PCI vs deferral of PCI) was analyzed. The primary outcome was target vessel failure (TVF) at 24 months, defined as a composite of cardiac death, target vessel myocardial infarction, and target vessel revascularization.

RESULTS:

Of 1,619 patients, 30% were women. Compared with men, women had a smaller minimal lumen area, smaller plaque burden, and higher FFR. They had a lower PCI rate (40.8% vs 47.9%; P = 0.008), which was mainly contributed by FFR guidance. Overall, women showed a lower TVF rate (2.4% vs 4.5%). According to the treatment type, the cumulative incidence of TVF was lower in women than in men among those with the deferral of PCI (1.7% vs 5.2%). However, this trend was not observed in patients who underwent PCI. In both women and men, there were no differences in clinical outcomes between the FFR- and IVUS-guided strategies.

CONCLUSIONS:

In cases of intermediate stenosis, despite receiving fewer interventions, women had more favorable outcomes than men. The use of FFR led to a lower PCI rate but had a similar prognostic value compared with IVUS in both women and men.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Coronary Artery Disease / Fractional Flow Reserve, Myocardial / Percutaneous Coronary Intervention Type of study: Clinical_trials / Guideline / Prognostic_studies Limits: Female / Humans / Male Language: En Journal: JACC Cardiovasc Interv Journal subject: ANGIOLOGIA / CARDIOLOGIA Year: 2023 Document type: Article Affiliation country:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Coronary Artery Disease / Fractional Flow Reserve, Myocardial / Percutaneous Coronary Intervention Type of study: Clinical_trials / Guideline / Prognostic_studies Limits: Female / Humans / Male Language: En Journal: JACC Cardiovasc Interv Journal subject: ANGIOLOGIA / CARDIOLOGIA Year: 2023 Document type: Article Affiliation country:
...